Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0000950170-24-032246

Options or other derivatives

  • Director acquired 50,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Zeiher Bernhardt G Director 2024-03-14 Grant or award · Stock Option (Right to Buy) +50,000 50,000 D
Loading xslF345X05/ownership.xml…